Anesthesiology
Conditions
Interventions
Group DE:Dexmedetomidine combined with esketamine
Sponsors
Inner Mongolia Erdos Central Hospital
Eligibility
Sex/Gender
All
Age
45 Years to 65 Years
Inclusion criteria
Inclusion criteria: Age 45 to 65 years; American Society of anesthesiologists (ASA) class I-II; SpO2 > 90%
Exclusion criteria
Exclusion criteria: Known local anesthetic allergy history (remazolam besylate, esmketamine, dexmedetomidine, midazolam, propofol); Previous pulmonary diseases (such as chronic obstructive pulmonary disease (COPD), respiratory failure and asthma); Severe sleep apnea syndrome (apnea hypopnea index > 40); Chronic renal failure (glomerular filtration rate 30 kg/m^2); Allergic to the drugs used in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Operation completion success rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| General information of the patient;Hemodynamics;Intraoperative anesthetic and vasoactive drug dosage;Time indicator;Infusion volume, intubation conditions, number of people needing remedial drugs;Mean oxygen saturation, minimum oxygen saturation, cough severity;Patient and bronchoscope physician satisfaction score; | — |
Countries
China
Contacts
Public ContactWei Li
Erdos CentrHospital of Inner Mongolia Autonomous Region
Outcome results
None listed